Cargando…

A shorter distal resection margin is a surrogate marker of nodal metastasis and poor prognosis in distal gastrectomy for advanced gastric cancer

BACKGROUND: Although a 3–5 cm surgical margin distance is recommended for advanced gastric cancer (GC) in Japanese guidelines, little is known about the clinical effects of the surgical margin, especially the distal resection margin (DM). This study aims to clarify the clinical significance of DM in...

Descripción completa

Detalles Bibliográficos
Autores principales: Takashima, Yusuke, Komatsu, Shuhei, Nishibeppu, Keiji, Ohashi, Takuma, Kosuga, Toshiyuki, Konishi, Hirotaka, Shiozaki, Atsushi, Kubota, Takeshi, Fujiwara, Hitoshi, Otsuji, Eigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629168/
https://www.ncbi.nlm.nih.gov/pubmed/37936119
http://dx.doi.org/10.1186/s12885-023-11570-2
_version_ 1785131908958519296
author Takashima, Yusuke
Komatsu, Shuhei
Nishibeppu, Keiji
Ohashi, Takuma
Kosuga, Toshiyuki
Konishi, Hirotaka
Shiozaki, Atsushi
Kubota, Takeshi
Fujiwara, Hitoshi
Otsuji, Eigo
author_facet Takashima, Yusuke
Komatsu, Shuhei
Nishibeppu, Keiji
Ohashi, Takuma
Kosuga, Toshiyuki
Konishi, Hirotaka
Shiozaki, Atsushi
Kubota, Takeshi
Fujiwara, Hitoshi
Otsuji, Eigo
author_sort Takashima, Yusuke
collection PubMed
description BACKGROUND: Although a 3–5 cm surgical margin distance is recommended for advanced gastric cancer (GC) in Japanese guidelines, little is known about the clinical effects of the surgical margin, especially the distal resection margin (DM). This study aims to clarify the clinical significance of DM in GC. METHODS: A total of 415 GC patients who underwent curative distal gastrectomy between 2008 and 2018 were analyzed retrospectively. RESULTS: The DM significantly stratified recurrence-free survival (P = 0.002), and a DM < 30 mm was an independent factor of a poor prognosis (P = 0.023, hazard ratio: 1.91). Lymphatic recurrence occurred significantly more frequently in the DM < 30 mm group than in the DM ≥ 30 mm group (P = 0.019, 6.9% vs. 1.9%). Regarding the station No.6 lymph node metastases in advanced GC (DM < 30 mm vs. 30 mm ≤ DM ≤ 50 mm vs. DM > 50 mm), the number (P < 0.001, 1.42 ± 1.69 vs. 1.18 ± 1.80 vs. 0.18 ± 0.64), the positive rate (P < 0.001, 59.0% vs. 46.7% vs. 11.3%) and therapeutic value index (43.3 vs. 14.5 vs. 8.0) were significantly higher in the DM < 30 mm group. By subdivision using the DM distance of 30 mm, more segmented prognostic stratifications were possible (P < 0.001). CONCLUSIONS: A DM of less than 30 mm could be a surrogate marker of poor RFS, especially increasing nodal recurrence. More intensive treatment strategies, including lymphadenectomy and chemotherapy, are needed for patients with this condition. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-11570-2.
format Online
Article
Text
id pubmed-10629168
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106291682023-11-08 A shorter distal resection margin is a surrogate marker of nodal metastasis and poor prognosis in distal gastrectomy for advanced gastric cancer Takashima, Yusuke Komatsu, Shuhei Nishibeppu, Keiji Ohashi, Takuma Kosuga, Toshiyuki Konishi, Hirotaka Shiozaki, Atsushi Kubota, Takeshi Fujiwara, Hitoshi Otsuji, Eigo BMC Cancer Research BACKGROUND: Although a 3–5 cm surgical margin distance is recommended for advanced gastric cancer (GC) in Japanese guidelines, little is known about the clinical effects of the surgical margin, especially the distal resection margin (DM). This study aims to clarify the clinical significance of DM in GC. METHODS: A total of 415 GC patients who underwent curative distal gastrectomy between 2008 and 2018 were analyzed retrospectively. RESULTS: The DM significantly stratified recurrence-free survival (P = 0.002), and a DM < 30 mm was an independent factor of a poor prognosis (P = 0.023, hazard ratio: 1.91). Lymphatic recurrence occurred significantly more frequently in the DM < 30 mm group than in the DM ≥ 30 mm group (P = 0.019, 6.9% vs. 1.9%). Regarding the station No.6 lymph node metastases in advanced GC (DM < 30 mm vs. 30 mm ≤ DM ≤ 50 mm vs. DM > 50 mm), the number (P < 0.001, 1.42 ± 1.69 vs. 1.18 ± 1.80 vs. 0.18 ± 0.64), the positive rate (P < 0.001, 59.0% vs. 46.7% vs. 11.3%) and therapeutic value index (43.3 vs. 14.5 vs. 8.0) were significantly higher in the DM < 30 mm group. By subdivision using the DM distance of 30 mm, more segmented prognostic stratifications were possible (P < 0.001). CONCLUSIONS: A DM of less than 30 mm could be a surrogate marker of poor RFS, especially increasing nodal recurrence. More intensive treatment strategies, including lymphadenectomy and chemotherapy, are needed for patients with this condition. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-11570-2. BioMed Central 2023-11-07 /pmc/articles/PMC10629168/ /pubmed/37936119 http://dx.doi.org/10.1186/s12885-023-11570-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Takashima, Yusuke
Komatsu, Shuhei
Nishibeppu, Keiji
Ohashi, Takuma
Kosuga, Toshiyuki
Konishi, Hirotaka
Shiozaki, Atsushi
Kubota, Takeshi
Fujiwara, Hitoshi
Otsuji, Eigo
A shorter distal resection margin is a surrogate marker of nodal metastasis and poor prognosis in distal gastrectomy for advanced gastric cancer
title A shorter distal resection margin is a surrogate marker of nodal metastasis and poor prognosis in distal gastrectomy for advanced gastric cancer
title_full A shorter distal resection margin is a surrogate marker of nodal metastasis and poor prognosis in distal gastrectomy for advanced gastric cancer
title_fullStr A shorter distal resection margin is a surrogate marker of nodal metastasis and poor prognosis in distal gastrectomy for advanced gastric cancer
title_full_unstemmed A shorter distal resection margin is a surrogate marker of nodal metastasis and poor prognosis in distal gastrectomy for advanced gastric cancer
title_short A shorter distal resection margin is a surrogate marker of nodal metastasis and poor prognosis in distal gastrectomy for advanced gastric cancer
title_sort shorter distal resection margin is a surrogate marker of nodal metastasis and poor prognosis in distal gastrectomy for advanced gastric cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629168/
https://www.ncbi.nlm.nih.gov/pubmed/37936119
http://dx.doi.org/10.1186/s12885-023-11570-2
work_keys_str_mv AT takashimayusuke ashorterdistalresectionmarginisasurrogatemarkerofnodalmetastasisandpoorprognosisindistalgastrectomyforadvancedgastriccancer
AT komatsushuhei ashorterdistalresectionmarginisasurrogatemarkerofnodalmetastasisandpoorprognosisindistalgastrectomyforadvancedgastriccancer
AT nishibeppukeiji ashorterdistalresectionmarginisasurrogatemarkerofnodalmetastasisandpoorprognosisindistalgastrectomyforadvancedgastriccancer
AT ohashitakuma ashorterdistalresectionmarginisasurrogatemarkerofnodalmetastasisandpoorprognosisindistalgastrectomyforadvancedgastriccancer
AT kosugatoshiyuki ashorterdistalresectionmarginisasurrogatemarkerofnodalmetastasisandpoorprognosisindistalgastrectomyforadvancedgastriccancer
AT konishihirotaka ashorterdistalresectionmarginisasurrogatemarkerofnodalmetastasisandpoorprognosisindistalgastrectomyforadvancedgastriccancer
AT shiozakiatsushi ashorterdistalresectionmarginisasurrogatemarkerofnodalmetastasisandpoorprognosisindistalgastrectomyforadvancedgastriccancer
AT kubotatakeshi ashorterdistalresectionmarginisasurrogatemarkerofnodalmetastasisandpoorprognosisindistalgastrectomyforadvancedgastriccancer
AT fujiwarahitoshi ashorterdistalresectionmarginisasurrogatemarkerofnodalmetastasisandpoorprognosisindistalgastrectomyforadvancedgastriccancer
AT otsujieigo ashorterdistalresectionmarginisasurrogatemarkerofnodalmetastasisandpoorprognosisindistalgastrectomyforadvancedgastriccancer
AT takashimayusuke shorterdistalresectionmarginisasurrogatemarkerofnodalmetastasisandpoorprognosisindistalgastrectomyforadvancedgastriccancer
AT komatsushuhei shorterdistalresectionmarginisasurrogatemarkerofnodalmetastasisandpoorprognosisindistalgastrectomyforadvancedgastriccancer
AT nishibeppukeiji shorterdistalresectionmarginisasurrogatemarkerofnodalmetastasisandpoorprognosisindistalgastrectomyforadvancedgastriccancer
AT ohashitakuma shorterdistalresectionmarginisasurrogatemarkerofnodalmetastasisandpoorprognosisindistalgastrectomyforadvancedgastriccancer
AT kosugatoshiyuki shorterdistalresectionmarginisasurrogatemarkerofnodalmetastasisandpoorprognosisindistalgastrectomyforadvancedgastriccancer
AT konishihirotaka shorterdistalresectionmarginisasurrogatemarkerofnodalmetastasisandpoorprognosisindistalgastrectomyforadvancedgastriccancer
AT shiozakiatsushi shorterdistalresectionmarginisasurrogatemarkerofnodalmetastasisandpoorprognosisindistalgastrectomyforadvancedgastriccancer
AT kubotatakeshi shorterdistalresectionmarginisasurrogatemarkerofnodalmetastasisandpoorprognosisindistalgastrectomyforadvancedgastriccancer
AT fujiwarahitoshi shorterdistalresectionmarginisasurrogatemarkerofnodalmetastasisandpoorprognosisindistalgastrectomyforadvancedgastriccancer
AT otsujieigo shorterdistalresectionmarginisasurrogatemarkerofnodalmetastasisandpoorprognosisindistalgastrectomyforadvancedgastriccancer